Emerging roles of proteases in tumour suppression
Top Cited Papers
- 1 October 2007
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 7 (10) , 800-808
- https://doi.org/10.1038/nrc2228
Abstract
Proteases have long been associated with cancer progression because of their ability to degrade extracellular matrices, which facilitates invasion and metastasis. However, recent studies have shown that these enzymes target a diversity of substrates and favour all steps of tumour evolution. Unexpectedly, the post-trial studies have also revealed proteases with tumour-suppressive effects. These effects are associated with more than 30 different enzymes that belong to three distinct protease classes. What are the clinical implications of these findings?Keywords
This publication has 98 references indexed in Scilit:
- Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis proteinMolecular Cancer Therapeutics, 2007
- ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2The EMBO Journal, 2006
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Rce1 deficiency accelerates the development of K-RAS–induced myeloproliferative diseaseBlood, 2006
- Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung MetastasesCancer Research, 2006
- Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumoursBritish Journal of Cancer, 2006
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Hypermethylation of the 5′ CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesisBritish Journal of Cancer, 2005
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationNature, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002